Over 10 years experience of Traceability Solutions

technique
30 Apr

By Pharmatrax Author

Category: Technoloy

Technique Reduces the Time It Takes To Discover Antibody-based Drugs No Comments

Technique Reduces the Time It Takes To Discover Antibody-based Drugs

Scientists have developed a technique that could significantly reduce the time to discover potential new antibody-based drugs to treat disease. Antibodies are produced by the…

Read More
protien
29 Apr

By Pharmatrax Author

Category: Technoloy

COVID-19 Drug Candidates Found by Targeting the Viral Protease No Comments

COVID-19 Drug Candidates Found by Targeting the Viral Protease

The SARS-CoV-2 viral genome encodes for 29 proteins—many of which could serve as potential targets for anti-viral drugs. In order to rapidly discover lead compounds…

Read More
coronavirus
25 Apr

By Pharmatrax Author

Category: News

Eurofins Discovery Supports Critical COVID-19 Drug Discovery Research with Products and Accelerated Drug Discovery Services No Comments

Eurofins Discovery Supports Critical COVID-19 Drug Discovery Research with Products and Accelerated Drug Discovery Services

Eurofins Discovery’s mission is to support Pharmaceutical and Biotech companies in their efforts to accelerate drug discovery research and development.  The COVID-19 crisis is putting…

Read More
23 Apr

By Pharmatrax Author

Category: Technoloy

‘Directing’ evolution to identify potential drugs earlier in discovery No Comments

‘Directing’ evolution to identify potential drugs earlier in discovery

Scientists have developed a technique that could significantly reduce the time of discovering potential new antibody-based drugs to treat disease. Antibodies are produced by the…

Read More
PolarisQB Fujitsu partner on drug discovery wrbm large
22 Apr

By Pharmatrax Author

Category: Technoloy

PolarisQB, Fujitsu partner on drug discovery No Comments

PolarisQB, Fujitsu partner on drug discovery

The two companies are combining their technologies to speed the process of bringing to market treatments for Dengue fever and other diseases. PolarisQB (based in…

Read More

By Pharmatrax Author

Category: Technoloy

Insilico and Boehringer to use AI for drug targets discovery No Comments

Insilico and Boehringer to use AI for drug targets discovery

Boehringer partners Insilico for AI-based discovery of drug targets. Credit: Madras150. Insilico Medicine has partnered with Boehringer Ingelheim to leverage artificial intelligence (AI) technology to…

Read More
CancerDD
17 Apr

By Pharmatrax Author

Category: Technoloy

Cancer Drug Discovery’s “RASzle-Dazzle” No Comments

Cancer Drug Discovery’s “RASzle-Dazzle”

Despite decades of research and therapeutic advances, cancer remains a global scourge and is currently the second leading cause of mortality. According to the American…

Read More
corona
16 Apr

By Pharmatrax Author

Category: News

Drug discovery in the age of coronavirus No Comments

Drug discovery in the age of coronavirus

Developing new drugs is incredibly hard. That’s why, despite superhuman efforts from the industry, we’re still looking at 12-18 months minimum before we can realistically…

Read More
ai
13 Apr

By Pharmatrax Author

Category: Technoloy

Big Pharma must share data to speed a covid-19 vaccine No Comments

Big Pharma must share data to speed a covid-19 vaccine

Large pharmaceuticals are hoarding data needed for a coronavirus cure. There is a precedent to share it, and retain commercial confidentiality. In brief Some of…

Read More
Transforming Drug Discovery Through Artificial Intelligence
15 Mar

By pharmatrax

Category: Technoloy

Transforming Drug Discovery Through Artificial Intelligence No Comments

Transforming Drug Discovery Through Artificial Intelligence

The emergence of Artificial Intelligence [AI] within the past few years has garnered either optimism, skepticism, or fear as we see an increase in adoption,…

Read More